Omvoh is an interleukin-23 antagonist. Omvoh is supplied in a single-dose vial containing 300mg/15mL solution for IV infusion and as a single-dose prefilled pen containing 100mg/mL solution for SC use ...

The lowest effective recommended dosage should be used to maintain therapeutic response. The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adult patients ...

ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis previously untreated with a biologic, but the integrin receptor ...

In this article, Dr Kamdar provides her insights on first-line oral therapy for severely active UC. The landscape for effective, accessible treatments for patients with moderately to severely active ...

Significantly more patients with moderately to severely active ulcerative colitis achieved clinical remission with the investigational monoclonal antibody tulisokibart compared with placebo, a ...

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. Ulcerative colitis affects the innermost lining of the colon and rectum.

A new drug, investigated by Amsterdam UMC together with colleagues around the world, is effective as a treatment against ulcerative colitis. With the clinical trial demonstrating a doubling in the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription ...

Add Yahoo as a preferred source to see more of our stories on Google. A patients receives treatment at Noble Infusion. Photo courtesy of Noble Infusion Dec. 3 (UPI) --Privately owned, standalone ...

Dec. 3 (UPI) --Privately owned, standalone infusion centers are increasingly providing a comfortable and convenient alternative to hospitals and doctors' offices for people on prescribed medications ...